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Introduction
It has been reported (1) that one effect
of a single, intra-peritoneal dose of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (dioxin) is to
cause a reduction in the duration of action
of the drug 2-amino-5-chlorobenzoxazole
(zoxazolamine) in the rat. This effect is
maximal with doses of dioxin above 100J,g/
kg and significant even at 5 jug/kg. Our own
work showed that oral dosage had a similar
effect but also that the duration of action
of hexobarbitone was consY(1erably pro-
longed (2). The results describc-d here ex-
tend these observations.
Materials and Methods
Animals
Rats of the albino Porton strain bred in
these Laboratories and weighing 180-200 g
(male 6-8 weeks and female 7-10 weeks old)
had free access to water and diet 41B un-
less otherwise indicated.
Mice of the C57BL/6 and DBA/2 strains
were bred in these laboratories and kept on
Sterolit bedding (Mineral & Chemical Cor-
poration of America, Menlo Park, New Jer-
sey, U.S.A.) for at least 3 weeks before use.
They had free access to diet and water.
*MRC Toxicology Unit, Medical Research Council
Laboratories, Woodmansterne Road, Carshalton,
Surrey, England.
Dosages
Dioxin, prepared as described elsewhere
(3), was administered as a solution (100 ug/
ml) in Arachis oil. Control animals received
an equivalent volume of oil. Zoxazolamine
(McNeil Laboratories, Inc.) was dissolved
in 1N HCI (1.2 ml/100 mg), diluted with
0.9%o NaCl to 10 mg/ml and administered
IP at 100 mg/kg. 5-Cyclo-hex-1'-enyl-1,5-di-
methylbarbituric acid (hexobarbitone) sod-
ium (May & Baker Ltd.) was dissolved in
water at 50 or 25 mg/ml and administered
IP at 150 mg/kg (male rats), 75 mg/kg (fe-
male rats), 100 mg/kg (male and female
mice). dl-Ethionine (Koch-Light) was dis-
solved in water (20 mg/ml) and administer-
ed as indicated in the text.
Microsomal Preparations
Liver microsomes were isolated either as
described by Bond and De Matteis (4), ex-
cept that the microsomes were sedimented
at 105,000g, or by the calcium/sucrose meth-
od (5) adapted to the extent of sediment-
ing the calcium-treated microsomes at 1900g
and washing them once in a 0.0125M sucrose
solution containing 8mM CaC12. The final
preparations were suspended in 0.1M phos-
phate buffer (pH 7.4) containing lmM Na2-
EDTA (1.4 -7.0 mg protein/ml). Protein
was estimated by the biuret method (6) and
cytochrome P-450 (or P-448) by using an
September 1973 211extinction coefficient of 91/mM-cm (7)
for the absorbancy change between 450
(448) and 490 nm of the CO difference spec-
trum of a Na2S204-reduced suspension.
Assays
Plasma barbiturate levels following hexo-
barbitone administration were measured by
the method of Chromy and Babjuk (8).
Hexobarbitone oxidase was measured in
vitro by the modified (9) method of Brodie
et al. (10).
Zoxazolamine hydroxylase was measured
by the methods of Burns and his colleagues
(11, 12) with minor modifications.
Difference Spectra
Difference spectra were recorded on a
Unicam SP 1800 spectrophotometer with oxi-
dized microsomal suspensions (2.7 ml, 1.4-
2.2 mg protein /ml) in each 1-cm cuvet and
the addition of either aniline (5-200 d,M 0.22-
M in 0.1M phosphate buffer, pH 7.4) or hex-
obarbitone sodium (5-100 MAl, 0.054M in wa-
ter) to the sample cuvet and of an equal
volume of the appropriate solvent to the re-
ference cuvet. Pyridine difference spectra
were recorded with Na2S2O4-reduced micro-
somal suspensions (2.7 ml) and 0.3 ml of
either 0.5M aqueous pyridine or water added
to the cuvets.
The wavelength of cytochrome P-450 (or
P-448) maximum absorption was measured
on a Cary 14 spectrophotometer calibrated
with a holmium filter.
Statistics
Results are quoted as the mean ± S. E. M.
and were analyzed by Student's t-test except
where the nature of the results necessitated
the use of a rankingtest.
Results and Discussion
Effect of Dioxin Administration on the
In Vivo Action, and In Vitro Metabolism of
Drugs in the Rat
One or 3 days after being given a single
oral dose of dioxin rats show a shortening
of the zoxazolamine paralysis time but an
increase in the duration of action of hexo-
barbitone (2). The effect on the hexobarbi-
tone sleeping time becomes progressively
more marked with time until, 2 weeks after
dosing, rats sleep over 4 hr and some of
them die without waking (Table 1).
Table 1. Effect of dioxin on the hexobarbitone sleeping time of male rats.a
Sleeping time, min b
Tdosimnger Dioxin (200,g/kg, over controls, P dosing ~P0) Solvent 0
12 hr 32.9 ± 3.5 (6) 37.7 ± 3.3 (5) NS
24 hr 40.0 ± 3.1 (6) 27.4 ± 1.8 (6) 46 <0.01
72 hr 75.5 ± 5.9 (6) 33.6 ± 3.3 (6) 125 <0.001
1 week 125.6 ± 14.1 (6) 21.5 ± 2.9 (5) 480 <0.001
2 weeks > 244 (6) 25.2 ± 2.7 (6) 870 0.0022
a Hexobarbitone sodium administered as described in Materials and Methods section.
b Numbers of animals in parentheses.
By ranking test.
In view of the prolonged reduction of food
intake of rats dosed with dioxin (3) it is
possible that a starvation effect (13) might
contribute significantly to the increased hexo-
barbitone sleeping times at later stages in
the intoxication (1 or 2 weeks after dos-
ing). However earlier experiments (2) had
suggested that, 1 day after dosing with di-
oxin, the reduced food intake was not the
sole cause of the prolongation of the hexo-
barbitone sleeping time. This interpretation
is open to criticism, since in these experi-
ments the animals had not been prefasted
before dioxin administration and the dioxin
might have slowed down the absorption of
the residual food in the stomach and intes-
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were starved for 39 hr and then dosed with
dioxin (200 /Ag/kg, PO) or oil. Following 24
hr further starvation the hexobarbitone
sleeping time was measured; the value for
the dosed group, 89.0 +3.8 min, was signific-
antly higher than that of the control group,
63.2 ±5.3 min, (P <0.005). Thus the early ef-
fect of dioxin on the sleeping time cannnot
be entirely due to differences in food con-
sumption or absorption between control
and treated animals. Therefore in all follow-
ing experiments we have used rats which
had been given a single dose of dioxin (200
/Ag/kg) 1 or 3 days previously.
It was considered possible that dioxin
might prolong the hexobarbitone sleeping
time by altering either the sensitivity of the
nervous system or the distribution of the
barbiturate within the body. These possibili-
ties were ruled out by an experiment in
which the sleeping times of groups of dioxin-
treated and control rats were measured and,
immediately after their waking, blood was
collected for the analysis of plasma barbi-
turate levels (8). Table 2 indicates that,
although there was a significant increase in
the sleeping time of the dosed animals, the
waking plasma barbiturate levels of the
two groups were not significantly different.
Table 2. Effect of dioxin on the sleeping time and
waking plasma barbiturate level of female rats.'
Plasma
Sleeping time, barbiturate,
Treatment N min ,ug/ml
Dioxin 6 99.3 ± 19.8 67.9 ± 2.2
Controls 6 45.9 ± 4.2 64.5 ± 2.9
P <0.025 NS
a Rats were dosed with dioxin (200 gg/kg, PO)
or oil and 3 days later the sleeping time in-
duced by hexobarbitone sodium (75 mg/kg,
IP) was measured. Immediately after waking
the animals were anesthetized (ether) and
blood collected from the heart. Plasma bar-
biturate was measured by the method of
Chromy and Babjuk (8).
Three days after a single oral dose of
either dioxin or oil to male or female rats
the liver microsomes were isolated and in-
cubated with an NADPH-generating system
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and either hexobarbitone or zoxazolamine
(Table 3). With either sex, following dioxin
treatment, there was a significant increase
in the amount of zoxazolamine metabolized,
and with males there was a significant de-
crease in the quantity of hexobarbitone oxi-
dized. With the microsomes from female rats
the control level of hexobarbitone metabol-
ism was lower than the males and, although
in the treated livers it was lower still, the
difference was not significant. Apart from
this, the results agree with the in vivo ex-
periments and indicate that dioxin modi-
fies the duration of the pharmacological ac-
tion of both zoxazolamine and hexobarbi-
tone by changing the rate of metabolism of
these drugs by the liver microsomes.
Table 3. Effect of dioxin treatment on the metabolism
of hexobarbitone and zoxazolamine by rat liver
microsomes.a
Zoxazolamine Hexobarbitone
metabolized, metabolized,
nmole/mg nmoles/mg
microsomal microsomal
Treatment Sex protein/hrb protein/hrb
Dioxin M 32.2 t 4.2 (10) 31.0 t 23.9 (5)
Controls M 15.7 ± 2.0 (10) 192.0 ± 18.7 (5)
P <0.005 <0.001
Dioxin F 46.9 ± 7.9 (5) 29.4 ± 47.8 (5)
Controls F 6.3 ± 5.4 (5) 109.2 ± 49.7 (5)
P <0.005 NS
ARats (180-200 g) received dioxin (200 ,ag/kg)
or oil PO and were killed 3 days later. Micro-
somes were isolated by the calcium/sucrose
method (see Materials and Methods) and the
assays performed essentially as described else-
where (9-12).
b Numbers of animals in parentheses.
Effect of Dioxin Administration on the Liver
Content and Spectral Properties of Micro-
somal Cytochrome P-450
Besides oxygen and NADPH, it is known
that three other components are required
for the reconstitution of a system capable
of metabolizing drugs in vitro. These are a
lipid, phosphatidyl choline; a flavoprotein,
NADPH/cytochrome P-450 reductase, and
a hemoprotein, cytochrome P-450 (or P-
448) (14-16). We have investigated the ef-
fect of dioxin treatment on cytochrome P-
450 of rat liver microsomes. Groups of male
213Table 4. Changes in liver weight and microsomal protein and cytochrome P-450 induced
by dioxin treatment of male rats."
Weight Microsomal Microsomal cytochrome P-450
wet liver, protein, nmoles/g nmoles/mg
Treatment g/100 g BW mg/g liver liver protein xmax (nm)
Dioxin 4.34 ± 0.12 26.5 ± 0.9 55.1 + 1.5 2.08 ± 0.07 447.6 ± 0.04
Controls 3.21 ± 0.06 27.3 + 0.6 28.1 ± 0.7 1.03 ± 0.02 449.6 ± 0.08
P <0.001 NS <0.001 <0.001 <0.001
a Rats received dioxin (200jug/kg, PO) or oil and 3 days later were killed and liver microsomes isolated
at 105,000g (see Materials and Methods). Each value is the mean of five observations.
rats received an oral dose of either dioxin
or oil and three days later were killed and
their liver microsomes isolated. Table 4 in-
dicates that there was a significant in-
crease in the weight of wet liver from the
treated animals. There was no increase in
the microsomal protein content, expressed
per gram of tissue, but the cytochrome con-
tent doubled. Further, the wavelength of
the peak maximum of the cytochrome spec-
trum was shifted from 450 nm to 448 nm.
Such a shift is a feature of the microsomal
enzyme induction brought about by com-
pounds such as 20-methylcholanthrene (17).
Since this inducer stimulates the metabolism
of aromatic compounds, including zoxazola-
mine (18) this change correlates well with
the observed stimulation of zoxazolamine
metabolism both in vivo and in vitro,. How-
ever it should be remembered that, if the
CO/cytochrome P-448 complex has an extinc-
tion coefficient more than four times that of
P-450, as has been reported (19), then there
has in fact been a decrease in hemo-protein
concentration.
The interaction of the reduced cytochrome
P-450 of liver microsomes with the ligands
ethyl isocyanide or pyridine is known to
result in the formation of a difference spec-
trum with two peaks in the region 400-460
nm (20). The relative intensity of these
two peaks, related to the absorption at 500
nm, is dependent on the pH of the suspend-
ing medium (20). In the case of liver
microsomes prepared from animals pre-
treated with 20-mO-thylcholanthrene and
therefore containing P-448 rather than P-
450, the curve of pH dependence of the peak
height ratio is so shifted that the peaks are
of equal intensity at a lower pH (21). The
pH dependence of the pyridine difference
spectra of microsomes from methylcholan-
threne-, dioxin- or oil-treated rats was
measured and is shown in Figure 1. It can be
seen that the curves due to dioxin or methyl-
cholanthrene treatment are similar to each
other but distinct from that of the control.
pH
FIGURE 1. Rats (male, 180-200 g) received dioxin
(200 u,g/kg, PO) or Arachis oil (2 ml/kg, PO)
3 days before killing. 20-Methylcholanthrene was
injected (20 mg/kg, 10 mg/ml in oil, IP) 3 and 2
days before killing. All were starved for 24 hr
before decapitation. Portions of liver microsomes
equivalent to 0.4 g of wet liver were isolated by
the calcium/sucrose method (5) and suspended in
0.1M P04 buffer (10 ml, containing lmM
Na2EDTA) of the appropriate pH. Pyridine differ-
ence spectra were measured as stated in Materials
and Methods.
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the cytochrome P-450 of liver microsomes
will interact with various substrates of the
drug metabolizing system to produce charac-
teristic difference spectra (22). We have
studied the effect of dioxin pretreatment of
rats on the interaction of aniline and hexo-
barbitone with rat liver microsomes. With
aniline the control microsomes showed a
normal Type II spectral change; this was
intensified in the case of the microsomes
from treated rats (Fig. 2). Such a change
is consistent with the increased cytochrome
P-448 in these preparations. However, a
double reciprocal plot of the spectral change/
nmole of P-450 (P-448) against aniline con-
centration indicated that there was an in-
crease in Ks (binding affinity constant)
and in the maximal Type II spectral change
(Fig. 3). A similar effect has been reported
following methylcholanthrene induction (23).
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FIGURE 2. Rats (male, 180-200 g) received dioxin
(200 ,ug/kg) or oil PO 3 days before killing. They
were starved for 24 hr before isolation of liver
microsomes at 105,000g. Preparations from two
animals were combined. Difference spectra (aniline
0.41mM final concentration) measured as de-
scribed in Materials and Methods on suspensions
containing microsomes equivalent to 0.073g wet
liver/ml.
FIGURE 3. Rats (male, 170-190 g) received dioxin
(200 ,ug/kg) or oil PO 3 days before killing. Liver
microsomes, equivalent to 2.8 g wet liver, were
isolated by the calcium/sucrose method (5) and
were suspended in 0.1M P04 buffer (25 ml, pH
7.4) containing lmM EDTA. Aniline concentra-
tions in the cuvet (see Materials and Methods)
were varied from 2.0 to 15.2mM. Each point is
the mean of observations on five animals. On each
axis the mean intercepts for groups of dosed and
control animals were significantly different (P <
0.05). An extinction coefficient of 91/mM-cm (7)
was used in the estimation of cytochrome P-450
(-448). The spectral changes observed are related
to the total cytochrome content of the cuvet.
The interaction of hexobarbitone with mi-
crosomes from control animals produced the
expected Type I difference spectra (22) as
illustrated in Figure 4. However the micro-
somal preparations from rats which had re-
ceived dioxin 3 days previously consistently
gave a difference spectrum with a peak at
412 nm and a trough at 380 nm. This type of
spectrum has been termed a modified Type
II spectral change (22) and has been ob-
served following methylcholanthrene pre-
treatment (24), but only with microsomal
preparations from female rats. A decrease
in the intensity of the Type I difference spec-
trum due to hexobarbitone has been reported
for methylcholanthrene-treated male and
female rats (23).
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FIGURE 4. All details as in the legend to Figure 2
except that hexobarbitone was added to the sample
Cuvetts to a concentration of 0.79mM.
Comparison of the Effects of 20-Methylchol-
anthrene and Dioxin on Zoxazolamine Action
in Mice of the DBA/2 Strain
All the changes of the properties of the
liver microsomes from dioxin-treated rats
are consistent with dioxin being a powerful
inducer of the methylcholanthrene type. It
has been reported that in mice of the
DBA/2 strain the levels of hepatic aryl hy-
drocarbon hydroxylase are unaffected by me-
thylcholanthrene (25) or benz[a]anthra-
cene (26) treatment. Indeed when DBA/2
mice (male, 20-30 g) were injected with
methylcholanthrene or oil as described by
Nebert et al. (25) we found, 24 hr after
injection, no significant difference between
the zoxazolamine paralysis times of the
treated and control groups (58.0 ±5.1 min,
N = 6 and 59.3 ± 3.9 min, N = 6, re-
spectively). This contrasts with C57BL/6
mice (male, 18-26 g) in which methylchol-
anthrene pretreatment significantly reduced
the paralysis time (dosed: 15.0 ± 1.0 min,
N = 9, controls: 79.5 ± 5.3 min, N = 9; P
<0.0001). However in both strains a single
oral dose of dioxin (200 ptg/kg) given 3 days
before zoxazolamine significantly lowered
the paralysis time (DBA/2, male, dosed:
10.5 ± 0.8 min, N = 6, controls: 65.7 ± 4.2
min, N = 5, P < 0.001; for C57BL/6 see
Table 5).
Table 5. Effect of dioxin on sleeping and paralysis times of C57 BL/6 mice."
Sleeping time, minb Paralysis time
Treatment Sex After 3 After 10 After 20 after 3
days days days days, min
Dioxin M 52.6 ± 6.2 (7) 60.6 ± 4.7 (7) >159.7 (7) 7.0 ± 0.7 (4)
Oil M 71.3 ± 3.8 (6) 60.2 ± 7.7 (4) 53.4 ± 7.3 (6) 46.8 ± 3.5 (5)
P <0.05 NS <0.01 C <0.001
Dioxin F 52.6 ± 6.5 (7) 5.9 ± 0.6 (5)
Oil F 65.1 ± 8.4 (7) - 37.7 ± 4.0 (7)
P NS <0.001
a Mice (11-27 g) received dioxin (200 ,ug/kg) or ol PO and hexobarbitone sodium or zoxazolamine af-
ter the stated intervals.
b Numbers of animals in parentheses.
By ranking test.
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the duration of zoxazolamine action is en-
tirely governed by the rate of metabolism
in the liver it would appear that the appar-
ent genetic noninducibility of hepatic aryl
hydrocarbon hydroxylase in certain mouse
strains is not an absolute trait but depend-
ent on the inducer used. This is in agree-
ment with the observations (26) that this
enzyme, although present in smaller amounts
in extrahepatic tissues, is inducible in such
organs of strains in which the liver enzyme
is unaffected.
Investigation of the Relationship between
Stimulation of Zoxazolamine Metabolism
and Inhibition of Hexobarbitone Metabolism
Although in the rat dioxin produces sim-
ultaneous and divergent effects on the met-
abolism of zoxazolamine and hexobarbitone
by liver microsomes, it is not known whether
these two effects are related to each other.
An alternative would be that dioxin has
two separate and distinct effects: the induc-
tion of zoxazolamine hydroxylase and the
depression of hexobarbitone oxidase. The
following two experiments indicate that,
after dioxin treatment, a stimulation of zo-
xazolamine metabolism can be observed in
the absence of any inhibition of hexobarbi-
tone metabolism.
In mice of the C57BL/6 strain, as in the
rat, a marked reduction of the zoxazola-
mine paralysis time was observed at 3 days
after dioxin treatment. However, at this
time the hexobarbitone sleeping time was
either unchanged (in female mice) or short-
ened (in male mice); a prolongation was
seen in males only at 20 days (Table 5).
Table 6. Effect of ethionine on dioxin-induced alterations in sleeping time and paralysis
time in rats.a
Route of administration
Sex Sleeping time, Paralysis time,
Dioxin Oil Ethionine min b min
M IP 75.4 ± 13.9 (5)C
IP 36.0 ± 2.2 (5)
M IP - PO 41.3 ± 3.6 (5) 84.0 ± 6.5 (5)d..
- IP PO 45.0 ± 3.1 (5) >383 (5)
M PO IP 44.7 ± 3.1 (6)
- PO IP 42.0 ± 3.4 (6)
F IP - PO 83.0 ± 9.4 (6) f 119.2 ± 9.4 (6)e
f
IP PO 136.4 ± 7.2 (6) >480 (6)
a Animals received dl-ethione (200, 100, and 100 mg/kg) at t = 0, 4, and 8 hr, respectively; dioxin (200
ag/kg) or oil at t = 0.5 hr and sleeping or paralysis times were measured at t = 24.5 hr. All were
starved during the experiment.
b Numbers of animals in parentheses.
e Significantly different from controls at P <0.05.
d Significantly different from controls at P <0.01.
e By ranking test.
f Significantly different from controls at P <0.005.
The effect of dioxin on hexobarbitone met-
abolism can also be suppressed in rats by
administering dl-ethionine together with
the dioxin. Along with a single oral dose of
dioxin male rats were given a series of in-
jections of dl-ethionine, an inhibitor of pro-
tein synthesis which has been reported as
preventing the induction of drug metabol-
ising enzymes by either 20-methylcholan-
threne (27) or phenobarbitone (28). It was
found (Table 6) that, whereas the ethionine
was ineffective in preventing the reduction
of paralysis time in dioxin-treated animals,
it did abolish the prolongation of hexobar-
bitone sleeping time due to dioxin treat-
ment. When the routes of administration
September 1973 217of dioxin and ethionine were interchanged
there was still no difference in hexobarbi-
tone metabolism.
When the experiment was carried out
with female rats, in which ethionine is a
more effective inhibitor of protein synthesis
(29), the duration of both paralysis and
sleep of the dioxin-treated animals was
shorter than that of the controls (Table
6). Thus although these doses of ethionine
are not effective in blocking the induced
metabolism of zoxazolamine (27) in either
sex, they are capable of preventing or even
reversing the effect of dioxin on hexobar-
bitone metabolism.
Conclusions
1. The divergent effects of dioxin on the
duration of action of hexobarbitone and zo-
xazolamine in the rat in vivo (2) are a
consequence of changes in hepatic metabol-
ism of these drugs.
2. Dioxin causes alterations in the proper-
ties of cytochrome P-450 of rat liver micro-
somes which are similar to those produced
by methylcholanthrene.
3. It is the most effective stimulator of
aromatic hydroxylation known, see (1), and
can apparently overcome a genetic resistance
to hepatic microsomal enzyme induction in
mice of the DBA/2 strain.
4. The effects of dioxin on hexobarbitone
and zoxazolamine metabolism can be separ-
ated by the use of C57BL/6 mice or ethion-
ine-treated rats and might be due to two
separate modes of action.
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